The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
<p>Abstract</p> <p>Background</p> <p>Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation of the active metabolite of c...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | http://www.thrombosisjournal.com/content/9/1/4 |